Crossmark

Validation of the Neoadjuvant Rectal Cancer (NAR) Score for Prognostication Following Total Neoadjuvant Therapy (TNT) for Locally Advanced Rectal Cancer

Crossref DOI link: https://doi.org/10.1007/s12029-022-00868-2

Published Online: 2022-10-17

Published Print: 2023-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Shah, Shivani

Asawa, Palash

Abel, Stephen

Wegner, Rodney E.
License Information

Text and Data Mining valid from 2022-10-17

Version of Record valid from 2022-10-17
More Information

Article History

Accepted: 27 September 2022

First Online: 17 October 2022

Declarations

:

: IRB approval was not obtained as the project did not include any interaction with participants nor intervention. This study was a retrospective study. All private information was de-identified.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below